Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-019755

President and CEO acquired 173,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chang David D · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-13 Grant or award : show line 1 in the form +173,000 2,168,625 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-13 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +292,700 292,700 D
Loading xslF345X03/doc4.xml…